Skip to main content
. 2024 Sep 1;45(47):5071–5083. doi: 10.1093/eurheartj/ehae579

Figure 8.

Figure 8

Event-free rate of occurrences of left ventricular ejection fraction <50%, left ventricular ejection fraction <40%, and treatment-emergent adverse events of cardiac failure over time. For patients with <56 days between enrolment periods, events contribute based on initial dosing (left ventricular ejection fraction <50% and left ventricular ejection fraction <40% analyses). LVEF, left ventricular ejection fraction